Director/PDMR Shareholding

In brief · summary, not quotable

Bioventix plc announced that its Non-Executive Chairman, Ian Nicholson, purchased 1,000 ordinary shares at 1,848 pence per share on April 10, 2026. Following this transaction, Mr. Nicholson beneficially owns 14,500 ordinary shares, representing approximately 0.3 per cent. of the company's issued share capital. This director dealing indicates confidence in the company's prospects.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your BVXP notes

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the Company was notified on 10 April 2026 that Ian Nicholson, Non-Executive Chairman, purchased a total of 1,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") at a price of 1,848 pence per Ordinary Share (the "Purchase").

Following the Purchase, Ian Nicholson has a beneficial interest in 14,500 Ordinary Shares, representing approximately 0.3 per cent. of the issued share capital of the Company.

	1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ian Nicholson
	2.	Reason for the Notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification/Amendment	Initial notification
a)	Name	Bioventix Plc
b)	LEI	213800225MHX7LZQY108
a)	Description of the Financial instrument, type of instrument	Ordinary Shares of 5 pence each
Identification code		GB00B4QVDF07
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	1,000 Ordinary Shares 1,848 pence
d)	Aggregated information: · Aggregated volume · Price	Single transaction as in 4c) above
e)	Date of the transaction	10 April 2026
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.